Skip to content

Compare

Wegovy vs Xenical

Last reviewed: September 2026Based on 2 clinical trials

Wegovy (semaglutide, weekly injection) and Xenical (orlistat, capsule, three times daily with meals) are both approved for weight loss in the United States. No head-to-head trial has compared these two drugs. The figures below come from separate trials, each with its own participants, length and comparison group.

At a glance

Wegovy and Xenical compared on form, trial results, cost and reported side effects
AttributeWegovyXenical
FormWeekly injection3x daily with meals
How oftenInjection: once-weeklyThree capsules daily, taken with each fat-containing meal
Weight loss in trialsUp to 14.9% — STEP 1 (68 weeks)Up to 8.5% — Sjostrom 1-year RCT (52 weeks)
FDA approved20211999
Made byNovo NordiskRoche (Xenical) / GSK (Alli OTC)
How it worksA GLP-1 analogue with an extended half-life of approximately one week.Blocks pancreatic lipase enzymes in the small intestine, preventing approximately 30% of dietary fat from being broken down and absorbed.
Monthly cost, self-pay$349–$399/mowith the manufacturer savings programme; list price ~$1,349$40–$400/moover-the-counter strength; prescription runs to $400
Most reported reactionNausea 44% (STEP 1)Oily/fatty stools (steatorrhoea) 27% (XENDOS)
Every figure in this table is read from the same trial and label records used everywhere else on this site.

Weight loss in each drug's main trial

No head-to-head trial has compared these two drugs.

Wegovy(semaglutide)14.9%

STEP 1 (68 weeks)

Xenical(orlistat)8.5%

Sjostrom 1-year RCT (52 weeks)

In clinical trials, participants taking semaglutide lost on average up to 14.9% of their starting body weight, and participants taking orlistat lost on average up to 8.5%. Those numbers come from two different studies: STEP 1 enrolled 1,961 adults with obesity or overweight with comorbidities, no type 2 diabetes over 68 weeks against placebo, while Sjostrom 1-year RCT enrolled 743 adults with obesity over 1 year (52 weeks) against placebo. Who took part, how long each trial ran and what each drug was measured against all move the percentage, so the two figures are not a measured difference between the drugs.

Monthly cost, self-pay

The bar spans the range in each drug's price record — lowest listed price to highest.

Wegovy$349–$399/mo

with the manufacturer savings programme; list price ~$1,349

Self-pay via NovoCare Pharmacy: $349/month for the 0.25–2.4 mg pens, $399/month for the Wegovy HD 7.2 mg pen. New patients pay a $199/month introductory price for the first two months on the 0.25 mg or 0.5 mg starting doses (offer runs through December 31, 2026, then the regular price applies). ~$25/month with eligible commercial insurance, capped at $100/month in savings. List price ~$1,349/month. The Wegovy pill is priced separately (see the oral pill entry). Per wegovy.com and novocare.com on 17 September 2026.

Xenical$40–$400/mo

over-the-counter strength; prescription runs to $400

Prescription Xenical ~$200–$400/month; over-the-counter Alli (60mg) ~$40–$60/month.

Self-pay prices are what the manufacturer or the pharmacy lists, not what most people end up paying. Wegovy: $349–$399/month. Xenical: $40–$400/month. Insurance, dose and pharmacy all change both figures.

Side effects reported in the trials

STEP 1 and XENDOS did not report the same reactions, so there is no shared row to line up. Each drug's own reported rates are listed below.

Wegovy
  • Nausea44%
  • Diarrhoea30%
  • Vomiting24%
  • Constipation24%

From STEP 1

Xenical
  • Oily/fatty stools (steatorrhoea)27%
  • Faecal urgency22%
  • Oily spotting on underwear27%
  • Faecal incontinence8%
  • Abdominal pain/discomfort14%

From XENDOS

A rate is the share of trial participants who reported that reaction, not a prediction for any one person.

How they differ in practice

How you take it

  • Wegovy — Two forms: once-weekly injection (2.4 mg) OR once-daily pill (25 mg). Same drug, similar results, very different cost and convenience.
  • Xenical — Oral capsule 120 mg, three times daily with meals (prescription). Also available OTC as Alli at 60 mg.

How soon it acts

  • Wegovy — Noticeable effects within 4–8 weeks; maximum weight loss typically reached by 60–68 weeks
  • Xenical — Weight effects begin from the first week (related to calorie malabsorption), but significant loss takes 8–12 weeks

Heart and metabolic findings

  • Wegovy — The SELECT trial (n=17,604) showed a 20% reduction in major adverse cardiovascular events against placebo.
  • Xenical — In the 4-year XENDOS trial, orlistat reduced progression from prediabetes to type 2 diabetes by 37% compared to placebo plus lifestyle changes.

As stated in each drug’s trial record — not a claim about which drug protects the heart more.

Other findings recorded

  • Wegovy — 20% reduction in heart attacks and strokes (SELECT trial, established CVD); improved blood pressure and cholesterol across STEP trials
  • Xenical — 37% reduction in progression to type 2 diabetes (XENDOS, 4 years); only approved obesity drug with a 4-year safety dataset

If you stop taking it

  • Wegovy — In STEP 4, stopping semaglutide after a 20-week run-in led to significant weight regain.
  • Xenical — Weight is typically regained after stopping.

Common questions

Written and maintained by one person · Built with agentic AI tools · Every number checked against the cited trial · Not medical advice

How this site is built →

Next step most people take

Built with agentic AI tools and not a substitute for medical advice

Last reviewed:

Was this page helpful?
Medical disclaimer: This website is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any treatment. Prices shown are United States self-pay or list prices and vary by insurance and country.